Judith K. Sato

1.8k total citations
28 papers, 803 citations indexed

About

Judith K. Sato is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Judith K. Sato has authored 28 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Judith K. Sato's work include Neuroblastoma Research and Treatments (11 papers), Sarcoma Diagnosis and Treatment (6 papers) and Cancer therapeutics and mechanisms (4 papers). Judith K. Sato is often cited by papers focused on Neuroblastoma Research and Treatments (11 papers), Sarcoma Diagnosis and Treatment (6 papers) and Cancer therapeutics and mechanisms (4 papers). Judith K. Sato collaborates with scholars based in United States, Canada and Japan. Judith K. Sato's co-authors include Mark Krailo, Gregory H. Reaman, Yoichi Hachitanda, Mark L. Bernstein, Chisa Aoyama, Hiroyuki Shimada, Nita L. Seibel, Sunita K. Patel, Richard Kadota and Claire Mazewski and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Analytical Biochemistry.

In The Last Decade

Judith K. Sato

27 papers receiving 787 citations

Peers

Countries citing papers authored by Judith K. Sato

Since Specialization

Citations

This map shows the geographic impact of Judith K. Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith K. Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith K. Sato more than expected).

Fields of papers citing papers by Judith K. Sato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith K. Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith K. Sato. The network helps show where Judith K. Sato may publish in the future.

Co-authorship network of co-authors of Judith K. Sato

This figure shows the co-authorship network connecting the top 25 collaborators of Judith K. Sato. A scholar is included among the top collaborators of Judith K. Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith K. Sato. Judith K. Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-Term Follow-up of High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Children and Young Adults with Metastatic or Relapsed Ewing Sarcoma: A Single-Institution Experience 2020 ·Transplantation and Cellular Therapy ·Anna Pawłowska, (unknown), George T. Calvert, Nicole Karras, Judith K. Sato, (unknown), Jerry C. Cheng, (unknown), (unknown), (unknown), Dongyun Yang, Andrew Dagis, James S. Miser, Joseph Rosenthal	2
2	Phase I study of liposomal formulation of eribulin (E7389-LF) in patients (pts) with advanced solid tumours: Primary results of dose-escalation part 2019 ·Annals of Oncology ·Nobuyuki Yamamoto, Judith K. Sato, Takahiko Koyama, Satoru Iwasa, Atsushi Shimomura, Shunsuke Kondo, Sho Kitano, Kan Yonemori, Yasuhiro Fujiwara, Kazuhiro Tamura, Takuya Suzuki, (unknown), Yutaka Nishiwaki, Kenya Nakai, Toshio Shimizu	4
3	Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL 2015 ·Journal of Immunotherapy ·Holly J. Meany, Nita L. Seibel, Mark Krailo, Doojduen Villaluna, Zhengjia Chen, Paul S. Gaynon, Joseph P. Neglia, Julie R. Park, Raymond J. Hutchinson, Judith K. Sato, Robert J. Wells, William G. Woods, Gregory Reaman	7
4	Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group 2015 ·Pediatric Blood & Cancer ·Cindy L. Schwartz, Leonard H. Wexler, Mark Krailo, Lisa A. Teot, Meenakshi Devidas, Laurel J. Steinherz, Allen M. Goorin, Mark C. Gebhardt, John H. Healey, Judith K. Sato, Paul A. Meyers, Holcombe E. Grier, Mark L. Bernstein, Steven E. Lipshultz	64
5	High Dose Chemotherapy (HDT) with Busulfan, Melphalan and Topotecan Followed by Autologous Hematopoietic Stem Cell Transplantation (ASCT) in Pediatric Patients (pts) with High Risk Solid Tumors 2012 ·Biology of Blood and Marrow Transplantation ·Anna Pawłowska, Julie Wolfson, Jerry C. Cheng, April Sorrell, Judith K. Sato, Craig S. Anderson, (unknown), (unknown), Stephen J. Forman, Joseph Rosenthal	3
6	Distress screening, rater agreement, and services in pediatric oncology 2010 ·Psycho-Oncology ·Sunita K. Patel, (unknown), (unknown), (unknown), (unknown), Judith K. Sato	78
7	Phase 2 Trial of Recombinant Tumor Necrosis Factor-α in Combination With Dactinomycin in Children With Recurrent Wilms Tumor 2008 ·Journal of Immunotherapy ·Holly J. Meany, Nita L. Seibel, Junfeng Sun, Jerry Z. Finklestein, Judith K. Sato, John F. Kelleher, Paul M. Sondel, Gregory Reaman	13
8	In Reply 2008 ·Journal of Clinical Oncology ·Paul A. Meyers, Cindy L. Schwartz, Mark Krailo, John H. Healey, William S. Ferguson, Mark C. Gebhardt, Allen M. Goorin, Eugenie S. Kleinerman, Michael L. Nieder, Robert J. Wells, Judith K. Sato, Holcombe E. Grier	2
9	High-dose therapy with hematopoietic stem cell rescue in patients with poor prognosis Ewing family tumors 2008 ·Bone Marrow Transplantation ·Joseph Rosenthal, Ellen Bolotin, (unknown), Anna Pawłowska, Peter Falk, Dongfu Qian, (unknown), Judith K. Sato, J. Miser, Stephen J. Forman	21
10	Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors 2007 ·Cancer ·H. Stacy Nicholson, Cynthia S. Kretschmar, Mark Krailo, Mark L. Bernstein, Richard Kadota, Daniel W. Fort, Henry S. Friedman, Michael B. Harris, (unknown), Claire Mazewski, Judith K. Sato, Gregory H. Reaman	138
11	Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma 2007 ·Cancer ·Nita L. Seibel, Mark Krailo, Zhengjia Chen, John H. Healey, Philip P. Breitfeld, Richard A. Drachtman, Brian Greffe, James B. Nachman, Helen Nadel, Judith K. Sato, Paul A. Meyers, Gregory H. Reaman	31
12	Phase II investigation of docetaxel in pediatric patients with recurrent solid tumors 2006 ·Cancer ·Ted Zwerdling, Mark Krailo, Philip Monteleone, Rebecca Byrd, Judith K. Sato, (unknown), Nita L. Seibel, Zhengjia Chen, John D. Strain, Gregory H. Reaman	50
13	A phase 2 trial of all‐trans‐retinoic acid in combination with interferon‐α2a in children with recurrent neuroblastoma or Wilms tumor: A Pediatric Oncology Branch, NCI and Children's Oncology Group Study 2006 ·Pediatric Blood & Cancer ·Peter C. Adamson, Katherine K. Matthay, M O'Brien, Gregory H. Reaman, Judith K. Sato, Frank M. Balis	35
14	Prospective Randomized Trial Between Two Doses of Granulocyte Colony-Stimulating Factor After Ifosfamide, Carboplatin, and Etoposide in Children With Recurrent or Refractory Solid Tumors: A Children's Cancer Group Report 2001 ·The American journal of pediatric hematology/oncology ·Mitchell S. Cairo, Violet Shen, Mark Krailo, Madeline Bauer, James S. Miser, Judith K. Sato, Julie Blatt, Bruce R. Blazar, Sharon Frierdich, Wen Liu‐Mares, Gregory H. Reaman	45
15	Phase I/II study of idarubicin given with continuous infusion fludarabine followed by continuous infusion cytarabine in children with acute leukemia: a report from the Children's Cancer Group. 1997 ·Journal of Clinical Oncology ·Patricia A. Dinndorf, Vassilios I. Avramis, Susan R. Wiersma, Mark Krailo, Wen Liu‐Mares, Nita L. Seibel, Judith K. Sato, Revonda B. Mosher, John F. Kelleher, Gregory H. Reaman	31
16	Ifosfamide and Etoposide in Recurrent Childhood Acute Lymphoblastic Leukemia 1995 ·Journal of Pediatric Hematology/Oncology ·Gay M. Crooks, Judith K. Sato	19
17	[Concentrations of new quinolone agents in serum and prostate tissue]. 1994 ·PubMed ·Katsuhiko Imai, Kazuhiko Suzuki, Hisashi Yamanaka, T. Makino, (unknown), (unknown), (unknown), (unknown), Judith K. Sato, Naoki Kato	1
18	Pleuropulmonary Blastoma in Childhood 1993 ·The American Journal of Surgical Pathology ·Yoichi Hachitanda, Chisa Aoyama, Judith K. Sato, Hiroyuki Shimada	32
19	Management of splenic abscess in immunocompromised children 1993 ·Journal of Pediatric Surgery ·(unknown), Masaki Nio, (unknown), Judith K. Sato, (unknown)	24
20	Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patients. 1990 ·PubMed ·Vassilios I. Avramis, Josette Champagne, Judith K. Sato, Mark Krailo, Lawrence J. Ettinger, David G. Poplack, Julia B. Finkelstein, Gregory H. Reaman, G. Denman Hammond, John S. Holcenberg	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact